2003•Unpublished venueRequires access

Effect of platelet-activating factor(PAF)antagonist SRI63-441 on ischemia-reperfusion injury of the myocardium in rats

Qingtang Wang

Open publisher page 0 citations

Abstract

Objective:TO study the effects of PAF antagonist SRI63-441 on ischemia-reperfusion(I/R)injury of the myocardium.Methods:Rat models of I/R were established with coronary occlusion and reperfusion of the left anterior descending artery (LAD). The rats were randomiy divided into 3groups:control group,reperfusion group and PAF goup. LAD of the rats in control group was not occluded.The rats in PAF group and reperfusion group were given SRI63-441(lmg/kg)and BSA-phosphoric-acid buffer solution by intravenous injection one minute before the occlusion of LAD,respectively.The change of arrhythmia,myocardial infarct size(MIS),superoside dismutase(SOD)activity and malondialdehyde(MDA)level were measured.Results:The MIS,severity of arrhythmia and levels of MDA decreased,while the activities of SOD increased.Conclusion:PAF might be an important mediator involved in myocardial reperfusion injury.PAF antagonist may be useful in the treatment of myocardial I/R injury.

About this research paper

What this paper is about

Objective:TO study the effects of PAF antagonist SRI63-441 on ischemia-reperfusion(I/R)injury of the myocardium.Methods:Rat models of I/R were established with coronary occlusion and reperfusion of the left anterior descending artery (LAD). The rats were randomiy divided into 3groups:control group,reperfusion group and PAF goup. LAD of the rats in control group was not occluded.The rats in PAF group and reperfusion group were given SRI63-441(lmg/kg)and BSA-phosphoric-acid buffer solution by intravenous injection one minute before the occlusion of LAD,respectively.The change of arrhythmia,myocardial infarct size(MIS),superoside dismutase(SOD)activity and malondialdehyde(MDA)level were measured.Results:The MIS,severity of arrhythmia and levels of MDA decreased,while the activities of SOD increased.Conclusion:PAF might be an important mediator involved in myocardial reperfusion injury.PAF antagonist may be useful in the treatment of myocardial I/R injury.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:TO study the effects of PAF antagonist SRI63-441 on ischemia-reperfusion(I/R)injury of the myocardium.Methods:Rat models of I/R were established with coronary occlusion and reperfusion of the left anterior descending artery (LAD). The rats were randomiy divided into 3groups:control group,reperfusion group and PAF goup. LAD of the rats in control group was not occluded.The rats in PAF group and reperfusion group were given SRI63-441(lmg/kg)and BSA-phosphoric-acid buffer solution by intravenous injection one minute before the occlusion of LAD,respectively.The change of arrhythmia,myocardial infarct size(MIS),superoside dismutase(SOD)activity and malondialdehyde(MDA)level were measured.Results:The MIS,severity of arrhythmia and levels of MDA decreased,while the activities of SOD increased.Conclusion:PAF might be an important mediator involved in myocardial reperfusion injury.PAF antagonist may be useful in the treatment of myocardial I/R injury.

Key concepts: Malondialdehyde, Antagonist, Platelet-activating factor, Reperfusion injury, Medicine, Occlusion, Ischemia, Receptor antagonist

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of platelet-activating factor(PAF)antagonist SRI63-441 on ischemia-reperfusion injury of the myocardium in rats — Research Paper | ScholarLens